FDA set to decide on GSK's gepotidacin antibiotic in March

FDA set to decide on GSK's gepotidacin antibiotic in March

Source: 
Pharmaphorum
snippet: 

The FDA has started a priority review of GSK's gepotidacin, which could become the first in a new class of oral antibiotics for uncomplicated urinary tract infections (uUTIs) in over 20 years.